GHC RESEARCH DEVELOPMENT CORPORATION
Patent Applications and Registrations
Patent applications and USPTO patent grants for GHC RESEARCH DEVELOPMENT CORPORATION.The latest application filed is for "hybrid cells for treating cancer patients".
- GHC RESEARCH DEVELOPMENT CORPORATION -
- GHC Research Development Corporation - Greenville SC
| Patent | Date |
|---|---|
| Hybrid cells for treating cancer patients App 20100047288 - Wagner; Thomas E. ; et al. | 2010-02-25 |
| VEGF receptor antagonists Grant 7,582,726 - Chen , et al. September 1, 2 | 2009-09-01 |
| Acetylated therapeutic procytotoxins Grant 7,550,426 - Wagner , et al. June 23, 2 | 2009-06-23 |
| Lytic peptide prodrugs Grant 7,456,146 - Yu , et al. November 25, 2 | 2008-11-25 |
| Therapeutic pore-forming peptides Grant 7,425,535 - Yu , et al. September 16, 2 | 2008-09-16 |
| Human prolactin antagonist-angiogenesis inhibitor fusion proteins Grant 7,339,027 - Chen March 4, 2 | 2008-03-04 |
| Stable episomal vectors Grant 7,294,505 - Wagner , et al. November 13, 2 | 2007-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 